Works about ANGIOTENSIN-receptor blockers
Results: 1959
Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic Dilated Cardiomyopathy.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 5, p. 416, doi. 10.3390/medicina57050416
- By:
- Publication type:
- Article
Fabrication and Comparative Assessment of Solid Dispersion and Nanosuspension in Solubility Enhancement of Antihypertensive Drug.
- Published in:
- Indian Journal of Pharmaceutical Education & Research, 2025, v. 59, p. 63, doi. 10.5530/ijper.20254202
- By:
- Publication type:
- Article
Pricing and Impact: Understanding Sales Trends and Price-Volume Distributions of Antihypertensive Drugs in Europe, USA, and India: Price-Volume Distributions in Hypertension Care: G. Satheesh et al.
- Published in:
- 2025
- By:
- Publication type:
- Letter
X-Ray Irradiation Induces Oxidative Stress and Upregulates Intestinal Nrf2-Mrp2 Pathway, Leading to Decreased Intestinal Absorption of Valsartan.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 268, doi. 10.3390/pharmaceutics17020268
- By:
- Publication type:
- Article
Preventative Effect of Angiotensin Receptor Blockers on Moderate-to-Severe Cerebral Vasospasm Among Patients Who Received Interventions for Aneurysmal Subarachnoid Hemorrhage.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 442, doi. 10.3390/biomedicines13020442
- By:
- Publication type:
- Article
Prevalence and Risk Factors for Acute Kidney Injury in COVID-19-Hospitalized Patients in Poland Across Three Pandemic Periods.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1384, doi. 10.3390/jcm14041384
- By:
- Publication type:
- Article
Are Newer Potassium Binding Agents Truly Better? Rethinking Sodium Polystyrene Sulfate and Emerging Therapies for Hyperkalemia: Emerging Therapies for Hyperkalemia: Mehta and Auguste.
- Published in:
- JGIM: Journal of General Internal Medicine, 2025, v. 40, n. 3, p. 516, doi. 10.1007/s11606-024-09107-9
- By:
- Publication type:
- Article
Pragmatic Clinical Decision Support Trial of Pre-checked Default Orders: Monitoring Safety and Adverse Clinical Outcomes: Adverse Clinical Outcomes of Clinical Decision Support: Kilgallon et al.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Efficacy and Safety of DALI-LDL-Apheresis in Two Patients Treated with the Angiotensin 11-Receptor 1 Antagonist Losartan.
- Published in:
- Therapeutic Apheresis & Dialysis, 2004, v. 8, n. 4, p. 269, doi. 10.1111/j.1526-0968.2004.00162.x
- By:
- Publication type:
- Article
Longitudinal Changes in Central Artery Stiffness with Lifestyle Modification, Washout, and Drug Treatment in Individuals at Risk for Cardiovascular Disease.
- Published in:
- Metabolic Syndrome & Related Disorders, 2010, v. 8, n. 4, p. 323, doi. 10.1089/met.2009.0099
- By:
- Publication type:
- Article
Sacubitril/Valsartan in Dialysis Patients: Update on Current Perspectives.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 187, doi. 10.1007/s10557-023-07481-w
- By:
- Publication type:
- Article
Beneficial Effects of Angiotensin II Receptor Blockers on Mortality in Patients with COVID-19: A Retrospective Study from 2019 to 2020 in China.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 63, doi. 10.1007/s10557-023-07494-5
- By:
- Publication type:
- Article
The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 4, p. 757, doi. 10.1007/s10557-021-07248-1
- By:
- Publication type:
- Article
Effects of Major Antihypertensive Drug Classes on Erectile Function: a Network Meta-analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 903, doi. 10.1007/s10557-021-07197-9
- By:
- Publication type:
- Article
Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 3, p. 483, doi. 10.1007/s10557-021-07155-5
- By:
- Publication type:
- Article
Effects of Angiotensin II Receptor Blockers on Ventricular Hypertrophy in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 2, p. 371, doi. 10.1007/s10557-020-07118-2
- By:
- Publication type:
- Article
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 6, p. 1183, doi. 10.1007/s10557-020-07128-0
- By:
- Publication type:
- Article
Transforming Growth Factor-β and the Renin-Angiotensin System in Syndromic Thoracic Aortic Aneurysms: Implications for Treatment.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 6, p. 1233, doi. 10.1007/s10557-020-07116-4
- By:
- Publication type:
- Article
Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study.
- Published in:
- Clinical & Experimental Nephrology, 2022, v. 26, n. 4, p. 350, doi. 10.1007/s10157-021-02159-9
- By:
- Publication type:
- Article
ACEi/ARBs associate with lower incidence of gastrointestinal bleeding in peritoneal dialysis patients.
- Published in:
- Clinical & Experimental Nephrology, 2022, v. 26, n. 3, p. 278, doi. 10.1007/s10157-021-02150-4
- By:
- Publication type:
- Article
Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 10, p. 1087, doi. 10.1007/s10157-021-02066-z
- By:
- Publication type:
- Article
Do you recommend tonsillectomy for elderly patients with IgA nephropathy?
- Published in:
- 2021
- By:
- Publication type:
- Letter
Chronological renal resistive index increases related to atherosclerotic factors, and effect of renin-angiotensin system inhibitors.
- Published in:
- Clinical & Experimental Nephrology, 2019, v. 23, n. 4, p. 513, doi. 10.1007/s10157-018-1667-y
- By:
- Publication type:
- Article
Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.
- Published in:
- Clinical & Experimental Nephrology, 2019, v. 23, n. 2, p. 215, doi. 10.1007/s10157-018-1631-x
- By:
- Publication type:
- Article
Combined administration of low-dose predonisolone and cyclosporine in idiopathic membranous nephropathy: Tsukuba's regimen for IMN.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Japanese subpopulation analysis of the RENAAL, the landmark trial, is welcomed by our society.
- Published in:
- Clinical & Experimental Nephrology, 2006, v. 10, n. 3, p. 226, doi. 10.1007/s10157-006-0430-y
- By:
- Publication type:
- Article
Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy.
- Published in:
- Clinical & Experimental Nephrology, 2003, v. 7, n. 3, p. 215, doi. 10.1007/s10157-003-0227-1
- By:
- Publication type:
- Article
Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study
- Published in:
- Clinical & Experimental Nephrology, 2003, v. 7, n. 3, p. 221, doi. 10.1007/s10157-003-0241-3
- By:
- Publication type:
- Article
Increased risk of major congenital malformations in early pregnancy use of angiotensin‐converting‐enzyme inhibitors and angiotensin‐receptor‐blockers: a meta‐analysis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 8, p. 1, doi. 10.1002/dmrr.3453
- By:
- Publication type:
- Article
SGLT2 inhibition to address the unmet needs in diabetic nephropathy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Investigation Planning and Bioequivalence evaluation of Angiotensin II Receptor Antagonists.
- Published in:
- Pharmaceutical Chemistry Journal, 2019, v. 53, n. 8, p. 680, doi. 10.1007/s11094-019-02062-4
- By:
- Publication type:
- Article
An insight into the role of telmisartan as PPAR‐γ/α dual activator in the management of nonalcoholic fatty liver disease.
- Published in:
- Biotechnology & Applied Biochemistry, 2022, v. 69, n. 2, p. 461, doi. 10.1002/bab.2123
- By:
- Publication type:
- Article
Telmisartan Reduces LPS-Mediated Inflammation and Induces Autophagy of Microglia.
- Published in:
- Neuroglia, 2024, v. 5, n. 2, p. 182, doi. 10.3390/neuroglia5020014
- By:
- Publication type:
- Article
Farmasötik Ürünler ve Ham Maddelerde N-Nitrozaminlerin Oluşum Mekanizması ve Toksisitesi: Sistematik Derleme.
- Published in:
- Journal of Literature Pharmacy Sciences, 2023, v. 12, n. 2, p. 171, doi. 10.5336/pharmsci.2022-94271
- By:
- Publication type:
- Article
Late-Onset Anaphylaxis due to Irbesartan.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
HEART FAILURE.
- Published in:
- Cardiovascular Innovations & Applications (CVIA), 2021, v. 6, p. C82
- Publication type:
- Article
IECA: A FISIOLOGIA POR TRÁS DA FARMACOLOGIA VETERINÁRIA.
- Published in:
- Revista Foco (Interdisciplinary Studies Journal), 2023, v. 16, n. 2, p. 1, doi. 10.54751/revistafoco.v16n2-121
- By:
- Publication type:
- Article
Angiotensin II Receptor Antagonist, Valsartan, Has Beneficial Effect in Lung Metastasis of Colorectal Cancer Treated with Fluorouracil.
- Published in:
- Iraqi Journal of Cancer & Medical Genetics, 2024, v. 17, p. 26
- By:
- Publication type:
- Article
Zilebesiran -- the first siRNA-based drug in hypertensiology: why is it needed, and will it change the treatment approach of hypertension?
- Published in:
- Arterial Hypertension, 2024, v. 28, p. 1, doi. 10.5603/ah.98623
- By:
- Publication type:
- Article
Ethnogeographic and inter-individual variability of human ABC transporters.
- Published in:
- Human Genetics, 2020, v. 139, n. 5, p. 623, doi. 10.1007/s00439-020-02150-6
- By:
- Publication type:
- Article
Losartan and dapagliflozin combination therapy in reducing uric acid level compared to monotherapy in patients with heart failure.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.18595
- By:
- Publication type:
- Article
Comparative proteinuria management of different angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for normotensive patients with CKD: a Bayesian network meta-analysis.
- Published in:
- PeerJ, 2020, p. 1, doi. 10.7717/peerj.8575
- By:
- Publication type:
- Article
Retrospective clinical study of renin-angiotensin system blockers in lung cancer patients with hypertension.
- Published in:
- PeerJ, 2019, p. 1, doi. 10.7717/peerj.8188
- By:
- Publication type:
- Article
AUSTRIAN SYNDROME: A RARE CASE REPORT.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Hiperpotasemia secundaria a uso combinado de un IECA o ARA II con espironolactona.
- Published in:
- Revista de Nefrología Diálisis y Trasplante, 2023, v. 43, n. 4, p. 228
- By:
- Publication type:
- Article
Crescentic IgA nephropathy following SARS-CoV-2 vaccination. Report of a case.
- Published in:
- Revista de Nefrología Diálisis y Trasplante, 2023, v. 43, n. 2, p. 106
- By:
- Publication type:
- Article
Beneficiile preparatelor antihipertensive la pacienţii cu hipertensiune arterială și glaucom.
- Published in:
- Farmacist.ro, 2022, n. 1, p. 22
- By:
- Publication type:
- Article
Antihypertension and Colorectal Cancer Prevention: Getting Two Birds With One Stone?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Effects of two different angiotensin receptor blockers on blood glucose level and HbA1c in type-2 diabetes mellitus patients with hypertension.
- Published in:
- Egyptian Journal of Internal Medicine, 2023, v. 35, n. 1, p. 1, doi. 10.1186/s43162-023-00256-7
- By:
- Publication type:
- Article
Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs.
- Published in:
- Cell Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41421-022-00454-7
- By:
- Publication type:
- Article